Schedule 13D ownership disclosure

REATA PHARMACEUTICALS INC

Security class unavailable · CUSIP: 75615P103

Event date: 2016-05-25

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
10.9300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-16-613928
Form type
SC 13D
Filer
Huff James Warren
CIK
CIK 1662411
Filed
Jun 06, 2016
Reporting period
May 25, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub